ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för asenapine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

25 träffar

Bibliografisk träff 2012-11-04

The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.

Tarazi FI, Neill JC.

Expert Opin Drug Discov · research support, non-u.s. gov't; review; journal article · DOI 10.1517/17460441.2013.738193

Bibliografisk träff 2012-10-25

Combination therapy for manic phases: a critical review of a common practice.

Geoffroy PA, Etain B, Henry C, Bellivier F.

CNS Neurosci Ther · research support, non-u.s. gov't; review-article; review; journal article · DOI 10.1111/cns.12017

Bibliografisk träff 2012-09-01

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.

De Hert M, Yu W, Detraux J, Sweers K, van Winkel R, Correll CU.

CNS Drugs · meta-analysis; research support, non-u.s. gov't; systematic review; journal article · DOI 10.2165/11634500-000000000-00000

Bibliografisk träff 2012-08-31

Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine.

Bartlett JA, van der Voort Maarschalk K.

AAPS PharmSciTech · research-article; journal article · DOI 10.1208/s12249-012-9839-7

Bibliografisk träff 2012-08-09

Asenapine for elderly bipolar manic patients.

Baruch Y, Tadger S, Plopski I, Barak Y.

J Affect Disord · clinical trial; journal article · DOI 10.1016/j.jad.2012.05.027

Bibliografisk träff 2012-08-04

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.

Azorin JM, Sapin C, Weiller E.

J Affect Disord · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jad.2012.07.013

Bibliografisk träff 2012-07-31

Iloperidone, asenapine and lurasidone: a primer on their current status.

Tarazi FI, Stahl SM.

Expert Opin Pharmacother · comparative study; review; journal article · DOI 10.1517/14656566.2012.712114

Bibliografisk träff 2012-06-15

Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia.

Cazorla P, Mackle M, Zhao J, Ha X, Szegedi A.

Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/ndt.s29891

Bibliografisk träff 2012-06-05

[Asenapine in bipolar disorder: efficacy, safety and place in clinical practice].

Samalin L, Tixeront C, Llorca PM.

Encephale · comparative study; review; journal article · DOI 10.1016/j.encep.2012.05.001

Bibliografisk träff 2012-06-01

▼Asenapine for bipolar I disorder?

Författaruppgift saknas

Drug Ther Bull · journal article · DOI 10.1136/dtb.2012.06.0112

Bibliografisk träff 2012-04-10

Asenapine: a clinical review of a second-generation antipsychotic.

Stoner SC, Pace HA.

Clin Ther · review; journal article · DOI 10.1016/j.clinthera.2012.03.002

Bibliografisk träff 2012-04-01

Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.

Chhalotiya UK, Bhatt KK, Shah DA, Patel JR.

Sci Pharm · research-article; journal article · DOI 10.3797/scipharm.1112-07

Bibliografisk träff 2012-03-27

Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.

Schoemaker J, Stet L, Vrijland P, Naber D, Panagides J, Emsley R.

Pharmacopsychiatry · multicenter study; randomized controlled trial; journal article · DOI 10.1055/s-0031-1301310

Bibliografisk träff 2012-03-16

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.

Frånberg O, Marcus MM, Svensson TH.

Synapse · research support, non-u.s. gov't; journal article · DOI 10.1002/syn.21551

Bibliografisk träff 2012-02-16

Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine.

de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H.

Biomed Chromatogr · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1002/bmc.2722

Bibliografisk träff 2012-02-15

Interactions between antiepileptics and second-generation antipsychotics.

de Leon J, Santoro V, D'Arrigo C, Spina E.

Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2012.660918

Bibliografisk träff 2012-02-01

Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.

Szegedi A, Calabrese JR, Stet L, Mackle M, Zhao J, Panagides J, Apollo Study Group.

J Clin Psychopharmacol · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; multicenter study; randomized controlled trial; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1097/jcp.0b013e31823f872f

Bibliografisk träff 2012-02-01

Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.

Buchanan RW, Panagides J, Zhao J, Phiri P, den Hollander W, Ha X, Kouassi A, Alphs L, Schooler N, Szegedi A, Cazorla P.

J Clin Psychopharmacol · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/jcp.0b013e31823f880a

Bibliografisk träff 2012-01-01

Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.

McIntyre RS, Wong R.

Clin Schizophr Relat Psychoses · review; journal article

Bibliografisk träff 2011-10-01

Asenapine: a new antipsychotic option.

Henry JM, Fuller MA.

J Pharm Pract · journal article · DOI 10.1177/0897190011422875

Bibliografisk träff 2011-08-23

Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.

Elsworth JD, Groman SM, Jentsch JD, Valles R, Shahid M, Wong E, Marston H, Roth RH.

Neuropharmacology · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.neuropharm.2011.08.026

Bibliografisk träff 2011-07-13

Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.

Dubovsky SL, Frobose C, Phiri P, de Greef R, Panagides J.

Int J Geriatr Psychiatry · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1002/gps.2737

Bibliografisk träff 2011-05-31

Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations.

Gerrits MG, de Greef R, Dogterom P, Peeters PA.

J Clin Pharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1177/0091270011404028

Bibliografisk träff 2011-05-06

Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.

de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H.

Biomed Chromatogr · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1002/bmc.1640

Bibliografisk träff 2011-03-01

Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.

Citrome L.

Postgrad Med · review; journal article · DOI 10.3810/pgm.2011.03.2273